Your browser doesn't support javascript.
loading
Neuroprotective Effects of σ2R/TMEM97 Receptor Modulators in the Neuronal Model of Huntington's Disease.
Jin, Jing; Arbez, Nicolas; Sahn, James J; Lu, Yan; Linkens, Kathryn T; Hodges, Timothy R; Tang, Anthony; Wiseman, Robyn; Martin, Stephen F; Ross, Christopher A.
Afiliación
  • Jin J; Division of Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore Maryland, 21287, United States.
  • Arbez N; Division of Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore Maryland, 21287, United States.
  • Sahn JJ; Cellular Sciences Department, IdRS, Croissy-sur-Seine 78290, France.
  • Lu Y; Department of Chemistry, The University of Texas at Austin, Austin, Texas 78712, United States.
  • Linkens KT; Department of Chemistry, The University of Texas at Austin, Austin, Texas 78712, United States.
  • Hodges TR; Department of Chemistry, The University of Texas at Austin, Austin, Texas 78712, United States.
  • Tang A; Department of Chemistry, The University of Texas at Austin, Austin, Texas 78712, United States.
  • Wiseman R; Division of Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore Maryland, 21287, United States.
  • Martin SF; Division of Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore Maryland, 21287, United States.
  • Ross CA; Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, United States.
ACS Chem Neurosci ; 13(19): 2852-2862, 2022 10 05.
Article en En | MEDLINE | ID: mdl-36108101
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_alzheimer_other_dementias / 6_mental_health_behavioral_disorders Asunto principal: Enfermedad de Huntington / Fármacos Neuroprotectores / Enfermedades Neurodegenerativas Límite: Animals / Humans Idioma: En Revista: ACS Chem Neurosci Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_alzheimer_other_dementias / 6_mental_health_behavioral_disorders Asunto principal: Enfermedad de Huntington / Fármacos Neuroprotectores / Enfermedades Neurodegenerativas Límite: Animals / Humans Idioma: En Revista: ACS Chem Neurosci Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos